Ulf Yrlid

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Immune Response

Dendritic Cells

Sentinel Lymph Node

Top Venues

Biomarker research

This page only lists publications with an associated author ORCID identifier.

Publications

Azar Rezapour, Daniel Rydbeck, Fabian Byvald, Viktor Tasselius, Gustaf Danielsson, Eva Haglind, Ulf Yrlid
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8 + T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma. Oncoimmunology 12 (1) (2023)
Azar Rezapour, Daniel Rydbeck, Fabian Byvald, Viktor Tasselius, Gustaf Danielsson, Eva Haglind, Ulf Yrlid
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8 + T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma. Oncoimmunology 12 (1) (2023)
Donia Kaidi, Louis Szeponik, Ulf Yrlid, Yvonne Wettergren, Elinor Bexe Lindskog
Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (9) (2022)
Frank Liang, Lisa M Nilsson, Fabian Byvald, Azar Rezapour, Helena Taflin, Jonas Andreas Nilsson, Ulf Yrlid
A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells. Cancers 14 (12) (2022)
Tobias Hofving, Frank Liang, Joakim Karlsson, Ulf Yrlid, Jonas Andreas Nilsson, Ola Nilsson, Lisa M Nilsson
The Microenvironment of Small Intestinal Neuroendocrine Tumours Contains Lymphocytes Capable of Recognition and Activation after Expansion. Cancers 13 (17) (2021)
Frank Liang, Azar Rezapour, Peter Falk, Eva Haglind, Ulf Yrlid
Cryopreservation of Whole Tumor Biopsies from Rectal Cancer Patients Enable Phenotypic and In Vitro Functional Evaluation of Tumor-Infiltrating T Cells. Cancers 13 (10) (2021)
Frank Liang, Azar Rezapour, Louis Szeponik, Samuel Alsén, Yvonne Wettergren, Elinor Bexe Lindskog, Marianne Quiding-Järbrink, Ulf Yrlid
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells. Cancers 13 (20) (2021)
Aylin Alkan, Tobias Hofving, Eva Angenete, Ulf Yrlid
Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients. Biomarker research 9 (1) (2021)
Gyusaang Youn, Jakob Cervin, Xiaoxi Yu, Surita R Bhatia, Ulf Yrlid, Nicole S Sampson
Targeting Multiple Binding Sites on Cholera Toxin B with Glycomimetic Polymers Promotes the Formation of Protein-Polymer Aggregates. Biomacromolecules 21 (12) (2020)
Jakob Cervin, Amberlyn M Wands, Anna Casselbrant, Han Wu, Soumya Krishnamurthy, Aleksander Cvjetkovic, Johanna Estelius, Benjamin Dedic, Anirudh Sethi, Kerri-Lee Wallom, Rebecca Riise, Malin Bäckström, Ville Wallenius, Frances Mary Platt, Michael Lebens, Susann Teneberg, Lars Fändriks, Jennifer J Kohler, Ulf Yrlid
GM1 ganglioside-independent intoxication by Cholera toxin. PLoS pathogens 14 (2) (2018)
Jayendra Kumar Krishnaswamy, Uthaman Gowthaman, Biyan Zhang, Johan Mattsson, Louis Szeponik, Dong Liu, Renee Wu, Tristan L A White, Samuele Calabro, Lan Xu, Magalie A Collet, Marina Yurieva, Samuel Alsén, Per Fogelstrand, Anne Walter, William R Heath, Scott N Mueller, Ulf Yrlid, Adam Williams, Stephanie C Eisenbarth
Migratory CD11b+ conventional dendritic cells induce T follicular helper cell-dependent antibody responses. Science immunology 2 (18) (2018)